BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 277244)

  • 1. Some aspects of the metabolism of misonidazole.
    Flockhart IR; Malcolm SL; Marten TR; Parkins CS; Ruane RJ; Troup D
    Br J Cancer Suppl; 1978 Jun; 3():264-7. PubMed ID: 277244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic and metabolic studies of the hypoxic cell radiosensitizer misonidazole.
    Flockhart IR; Large P; Troup D; Malcolm SL; Marten TR
    Xenobiotica; 1978 Feb; 8(2):97-105. PubMed ID: 415443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical studies with misonidazole.
    Wiltshire CR; Workman P; Watson JV; Bleehen NM
    Br J Cancer Suppl; 1978 Jun; 3():286-9. PubMed ID: 277246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of hypoxic cell radiosensitizers: a review.
    Workman P
    Cancer Clin Trials; 1980; 3(3):237-51. PubMed ID: 7438321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the fate of misonidazole (RO 07-0582) and its metabolite desmethylmisonidazole (RO 05-9963), two hypoxic cell radiosensitizers: penetration properties in tumor bearing rats.
    Akel G; Canal P; Mockey E; Vandevoorde E; Laurent F; Soula G
    J Pharmacol; 1983; 14(1):67-77. PubMed ID: 6834852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The hypoxic cell sensitizer programme in the United States.
    Phillips TL; Wasserman TH; JohnsonRJ ; Gomer CJ; Lawrence GA; Levine ML; Sadee W; Penta JS; Rubin DJ
    Br J Cancer Suppl; 1978 Jun; 3():276-80. PubMed ID: 277245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies in radiosensitizing effects of misonidazole and SR-2508 on C3H/He mouse mammary tumors.
    Ono K; Takahashi M; Nishidai T; Dodo Y; Shibamoto Y; Hiraoka M; Yukawa Y; Abe M
    Radiat Med; 1984; 2(1):71-5. PubMed ID: 6242712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of 2-nitroimidazoles as bioreductive markers for tumour hypoxia.
    Hodgkiss RJ
    Anticancer Drug Des; 1998 Sep; 13(6):687-702. PubMed ID: 9755725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The metabolism and pharmacokinetics of the hypoxic cell radiosensitizer and cytotoxic agent, misonidazole, in C3H mice.
    Chin JB; Rauth AM
    Radiat Res; 1981 May; 86(2):341-57. PubMed ID: 7232696
    [No Abstract]   [Full Text] [Related]  

  • 10. Glutathione depletion by 2-nitroimidazole-1-acetohydroxamic acid as a radiosensitizer in hypoxic rat hepatocytes.
    Takanuki K; Igarashi T; Hata K; Hori H; Shibata T; Kitagawa H; Satoh T; Inayama S
    Biochem Int; 1988 Jul; 17(1):155-62. PubMed ID: 3190713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of binding of [3H]misonidazole and [14C]misonidazole in multicell spheroids.
    Rasey JS; Grunbaum Z; Krohn K; Nelson N; Chin L
    Radiat Res; 1985 Mar; 101(3):473-9. PubMed ID: 3983363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of hypoxic radiosensitizer after mild hyperthermia in C3H mammary carcinoma.
    Ohizumi Y; Murayama C; Maezawa H; Mori T
    Tokai J Exp Clin Med; 1984 Oct; 9(4):331-7. PubMed ID: 6537042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiosensitization, pharmacokinetics, and toxicity of a 2-nitroimidazole nucleoside (RA-263).
    Agrawal KC; Rupp WD; Rockwell S
    Radiat Res; 1986 Feb; 105(2):227-39. PubMed ID: 3754053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of the hypoxic radiosensitizers misonidazole and demethylmisonidazole after intraperitoneal administration in humans.
    Gianni L; Jenkins JF; Greene RF; Lichter AS; Myers CE; Collins JM
    Cancer Res; 1983 Feb; 43(2):913-6. PubMed ID: 6848201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiosensitization of human colorectal tumor cells by 4-nitro-5-sulfonatoimidazoles.
    Fitzpatrick DA; Heindel ND; Egolf RA; Walton H
    Radiat Res; 1989 Jan; 117(1):47-58. PubMed ID: 2913608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Present status of radiation sensitizers--hypoxic cell radiosensitizer].
    Murayama C; Mori T
    Gan To Kagaku Ryoho; 1989 Jun; 16(6):2135-41. PubMed ID: 2660744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pharmacokinetics and tumor and neural tissue penetrating properties of SR-2508 and SR-2555 in the dog--hydrophilic radiosensitizers potentially less toxic than misonidazole.
    White RA; Workman P; Brown JM
    Radiat Res; 1980 Dec; 84(3):542-61. PubMed ID: 6450431
    [No Abstract]   [Full Text] [Related]  

  • 18. [Radiosensitizer: hypoxic cell radiosensitizer].
    Mori T
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-2):1399-404. PubMed ID: 2525001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of acidic pH on radiosensitization of FSaIIC cells in vitro by misonidazole, etanidazole, or cis-diamminedichloroplatinum (II).
    Herman TS; Teicher BA; Pfeffer MR; Khandekar V; Chapnick RM; Kalick GS; Rabow A
    Radiat Res; 1990 Oct; 124(1):28-33. PubMed ID: 2146699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro metabolism of misonidazole.
    Josephy PD; Palcic B; Skarsgard LD
    Br J Cancer; 1981 Apr; 43(4):443-50. PubMed ID: 7236487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.